Category Archives: BioUtah News

BioUtah yesterday held its 2023 Utah Life Sciences Summit, presented by Mayer Brown. Every year, the Summit is the largest gathering of Utah’s life sciences industry. This year was no exception. Following welcome remarks from Gov. Spencer Cox, a distinguished line-up of top executives addressed a packed house. Keynote speaker, Joseph Smith, chief scientific officer […]

SALT LAKE CITY – November 3, 2023 – BioUtah today announced the winners of its 2023 Life Sciences Awards. Five awards will be presented during the 2023 Mayer Brown Utah Life Sciences Summit Nov. 9 at the Salt Palace, in Salt Lake City. BioUtah’s annual awards recognize leaders, innovators and entrepreneurs who have made significant […]

Springville, Utah, October 27, 2023—ATL Technology, a dynamic and rapidly expanding company specializing in medical device development and manufacturing, is thrilled to introduce Danelle Goulet as the new Vice President of Human Resources. Expressing her enthusiasm for her new role, Danelle shared, “I am excited by the challenge of a fast-growing company in the medical […]

BD Prevue™ II System Equips Clinicians with Connected Ultrasound Technology to Drive More Intuitive IV Placement and Control FRANKLIN LAKES, N.J. (April 11, 2023) – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today launched a new, easy-to-use advanced ultrasound device with a specialized probe designed to provide clinicians with […]

First-in-Human Study of Novel Oral Dual-Acting Antibody in Development for Treatment of Patients with Inflammatory Bowel Disease SALT LAKE CITY, UT, UNITED STATES, November 1, 2023 /EINPresswire.com/ — Sorriso Pharmaceuticals, a biopharmaceutical company developing novel oral antibodies in immune-mediated disease, today announced that the first subject has been dosed in the company’s Phase 1/1b clinical […]

SALT LAKE CITY – October 27, 2023 –BioUtah, Utah’s trade association serving the state’s life sciences community, announced today Myles Greenberg, MD, MBA, CEO of Alucent Biomedical, as the new board chair, effective January 2024. Dr. Greenberg, an experienced life sciences entrepreneur, venture investor, and board-certified emergency physician, succeeds Andrea Kendell, chief financial officer at […]